+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lung Marker Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • PDF Icon

    Report

  • 141 Pages
  • July 2023
  • Region: Global
  • IMARC Group
  • ID: 5656490
The global lung marker market size reached US$ 393.0 Million in 2022. Looking forward, the publisher expects the market to reach US$ 731.0 Million by 2028, exhibiting a growth rate (CAGR) of 11.5% during 2023-2028.

Generally, four major types of lung markers, including EGFR, EML4-ALK, KRAS, and BRAF, are used during lung intervention procedures or lung surgeries and diagnosis. Furthermore, the markers are used to detect, diagnose, predict, and monitor the tumor, based on which the treatment is prescribed to the patient. Lung markers are only used as an additional tool to identify cancer along with several imaging tests and biopsy. Owing to this, lung markers are extensively used in thoracoscopic surgeries across hospitals, ambulatory surgical clinics, and specialty clinics, among several other healthcare facilities.

The rising demand for lung markers can be attributed to the high prevalence of respiratory disorders, such as pleural effusion, pleural mesothelioma, pleural plaque, etc., due to the increasing air pollution levels, across the globe. Besides this, the high exposure to passive smoking, along with a family history of lung cancer further drives the number of patients suffering from lung cancer, thereby augmenting the demand for lung markers. Additionally, the surging geriatric population, along with the hectic consumer lifestyles leading to a high smoking rate, further accelerate the risks of several respiratory disorders. Apart from this, the increasing healthcare expenditures by various governments for early diagnosis and pre-treatment of life-threatening diseases, such as lung cancer, are also propelling the rising utilization of lung markers at a global level. Furthermore, rising investments in several research and development activities in the field of lung cancer diagnostics and treatment is further catalyzing the demand for lung markers. In addition to this, the increasing usage of lung markers in hospitals, surgery centers, clinics, and their various applications in therapeutic purposes has also catalyzed the product demand.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global lung marker market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on cancer type, marker type and end user.

Breakup by Cancer Type:

  • Non-Small Cell Lung Cancer (NSCLC)
  • Small Cell Lung Cancer (SCLC)

Breakup by Marker Type:

  • EGFR
  • EML4-ALK
  • KRAS
  • BRAF
  • Others

Breakup by End User:

  • Hospitals
  • Diagnostic Labs
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Others
  • Middle East and Africa
  • Turkey
  • Iran
  • Others

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Fujirebio Europe N.V., Hologic, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers, and BioSpace, Inc.

Key Questions Answered in This Report:

  • How has the global lung marker market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global lung marker market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the marker type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global lung marker market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Lung Marker Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact Of COVID-19
5.4 Market Forecast
6 Market Breakup by Cancer Type
6.1 Non-Small Cell Lung Cancer (NSCLC)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Small Cell Lung Cancer (SCLC)
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Marker Type
7.1 EGFR
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 EML4-ALK
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 KRAS
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 BRAF
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Diagnostic Labs
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Europe
9.2.1 Germany
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 France
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 United Kingdom
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 Italy
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Spain
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Russia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Asia Pacific
9.3.1 China
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 Japan
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 India
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 South Korea
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Australia
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Indonesia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Argentina
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.4.4 Colombia
9.4.4.1 Market Trends
9.4.4.2 Market Forecast
9.4.5 Chile
9.4.5.1 Market Trends
9.4.5.2 Market Forecast
9.4.6 Peru
9.4.6.1 Market Trends
9.4.6.2 Market Forecast
9.4.7 Others
9.4.7.1 Market Trends
9.4.7.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Turkey
9.5.1.1 Market Trends
9.5.1.2 Market Forecast
9.5.2 Iran
9.5.2.1 Market Trends
9.5.2.2 Market Forecast
9.5.3 Others
9.5.3.1 Market Trends
9.5.3.2 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Indicators
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Thermo Fisher Scientific Inc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Agilent Technologies, Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Beckman Coulter, Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Fujirebio Europe N.V., Hologic, Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 F. Hoffmann-La Roche Ltd
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Siemens Healthineers
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 BioSpace, Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
List of Figures
Figure 1: Global: Lung Marker Market: Major Drivers and Challenges
Figure 2: Global: Lung Marker Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Lung Marker Market: Breakup by Cancer Type (in %), 2022
Figure 4: Global: Lung Marker Market: Breakup by Marker Type (in %), 2022
Figure 5: Global: Lung Marker Market: Breakup by End User (in %), 2022
Figure 6: Global: Lung Marker Market: Breakup by Region (in %), 2022
Figure 7: Global: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 8: Global: Lung Marker (NSCLC) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Lung Marker (NSCLC) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Lung Marker (SCLC) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Lung Marker (SCLC) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Lung Marker (EGFR) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Lung Marker (EGFR) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Lung Marker (EML4-ALK) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Lung Marker (EML4-ALK) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Lung Marker (KRAS) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Lung Marker (KRAS) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Lung Marker (BRAF) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Lung Marker (BRAF) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Lung Marker (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Lung Marker (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Lung Marker (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Lung Marker (Diagnostic Labs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Lung Marker (Diagnostic Labs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Lung Marker (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: United States: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: United States: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Canada: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Canada: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia Pacific: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia Pacific: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: China: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: China: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Japan: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Japan: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: India: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: India: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: South Korea: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: South Korea: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Australia: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Australia: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Indonesia: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Indonesia: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Others: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Germany: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Germany: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: France: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: France: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: United Kingdom: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: United Kingdom: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Italy: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Italy: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Spain: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Spain: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Russia: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Russia: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Middle East and Africa: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Middle East and Africa: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Turkey: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Turkey: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Iran: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Iran: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Latin America: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Latin America: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Brazil: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Brazil: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Mexico: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Mexico: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Argentina: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Argentina: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Colombia: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Colombia: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Chile: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Chile: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Peru: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Peru: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Others: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 89: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Global: Lung Marker Industry: SWOT Analysis
Figure 91: Global: Lung Marker Industry: Value Chain Analysis
Figure 92: Global: Lung Marker Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Lung Marker Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Lung Marker Market Forecast: Breakup by Cancer Type (in Million US$), 2023-2028
Table 3: Global: Lung Marker Market Forecast: Breakup by Marker Type (in Million US$), 2023-2028
Table 4: Global: Lung Marker Market Forecast: Breakup by End Use (in Million US$), 2023-2028
Table 5: Global: Lung Marker Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Lung Marker Market: Competitive Structure
Table 7: Global: Lung Marker Market: Key Players

Companies Mentioned

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • Beckman Coulter Inc.
  • Fujirebio Europe N.V.
  • Hologic Inc.
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers
  • BioSpace Inc.

Methodology

Loading
LOADING...

Table Information